In-room imaging and MR planning

Study Population: RT Patients at Risk

1. Untreated high-risk (NCCN) and CAPRA > 5, M0 2. Post-treatment biochemical failure, M0 – Post RT: Local failure (biopsy +ve) – Post RP: Salvage of BF 3. Oligometastatic disease (≤5, regional or distant) planned for SBRT

Exclusion: HT at consent